Skip to main content

Post-market review of nucleic acid tests

The TGA is undertaking desktop analysis of all NAT kits on the ARTG to determine whether they will be impacted by the known variants, with ongoing activity to assess their ability to detect all emerging variants of interest.

Last updated

Help us improve the Therapeutic Goods Administration site